Slade Health opens new compounding facility in SA
08 November, 2023Cancer care provider Icon Group's compounding arm, Slade Health, has opened a new TGA licensed facility in Woodville, South Australia.
Sydney children's hospitals to receive positive pressure rooms
06 November, 2023Using a specialised air ventilation system, these rooms function as a protective shield for some of the sickest and most vulnerable children.
New mRNA network to accelerate clinical translation
06 November, 2023The network aims to advance mRNA medicine, foster scientific excellence in clinical translation and further the therapeutic potential of the mRNA platform.
Novel intervention to improve strength, mobility in rheumatoid arthritis
06 November, 2023A novel exercise intervention being trialled by the University of South Australia researchers, in partnership with Arthritis SA, could help improve physical function and quality of life in people.
Extreme weather injuries on the increase
03 November, 2023New research shows that Australian hospital admissions for injuries resulting from extreme weather have increased — especially those relating to heat.
Alarming resistance rates prompt calls for updated antibiotic guidelines
01 November, 2023Antibiotics to treat common infections in children and babies are no longer effective, due to high rates of resistance, reveals new research.
Getinge PICCO hemodynamic monitoring solution
01 November, 2023 | Supplied by: Getinge Australia Pty LtdGetinge's advanced hemodynamic monitoring solution PiCCO is designed to provide a minimally invasive measurement of cardiac output and its determinants (preload, afterload, contractility) as well as the quantification of pulmonary oedema through the measuring of the extravascular lung water index (ELWI).
Toolkit to guide health professionals on managing menopause
31 October, 2023Monash University has led the development of a toolkit aimed at guiding health professionals around the world in assessing and treating women with menopausal health issues.
AF diagnosis linked to mild cognitive decline
31 October, 2023Atrial fibrillation (AF) diagnosis was linked to a 45% increased risk of mild cognitive impairment (MCI) among a cohort of 4.3 million individuals in the UK.
Infectious diseases researcher recognised
30 October, 2023UNSW infectious diseases researcher Dr Lise Lafferty has been recognised with the Paul Bourke Award for her approach to managing hepatitis C in prisons.
Hospital–university partnership increases access to rare cancer care
27 October, 2023Access to personalised cancer treatments and the sharing of genetic testing information are among the aims of a new Monash Partners Comprehensive Cancer Consortium program.
Links between physical job risks and preterm birth: study
27 October, 2023The Monash University-led study found that pregnant women were at significantly increased risk of preterm birth if they worked long hours or in shift work.
Study reveals barriers to accessing low-cost ketamine
25 October, 2023Australian researchers have investigated why many patients with severe depression are unable to access potentially life-saving treatments.
Extra antibiotics to prevent joint replacement infections don't help: trial
23 October, 2023A clinical trial has found that in joint replacement infection, the addition of vancomycin may lead to more infections and more adverse reactions for the patients.
trophon2®: confidence without compromise
23 October, 2023 | Supplied by: Nanosonics LimitedThe trophon2 device is the latest addition to the trophon family. It has an enhanced user experience and offers health professionals the confidence of the broadest microbial efficacy, plus digital traceability and consistent protection for every patient, every time.
